TrialPath
Psoriasis · San Diego

Psoriasis clinical trials in San Diego

4 recruiting psoriasis studies within range of San Diego. Click any trial for full eligibility criteria and contact info.

A Study to Assess Deucravacitinib Safety in Pregnancy

NCT07017699 · Psoriasis (PsO)
Recruiting

The purpose of this study is to assess pregnancy and infant outcomes among pregnant participants enrolled in an established North American pregnancy registry (Organization of Teratology Information Specialists \[OTIS\]) who were exposed to deucravacitinib.

Phase—
TypeObservational
AgeAny
WhereLa Jolla, California, United States
SponsorBristol-Myers Squibb
▾Tap for details
Apply

Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy

NCT06586281 · Psoriatic Arthritis
Recruiting

While many studies examine Nonalcoholic fatty liver disease (NAFLD), little is known about its progression to high-risk nonalcoholic steatohepatitis (NASH) in PsA patients. Shared disease mechanisms may explain the increased severity in PsA. This study involves two visits from PsA patients with NAFLD and active disease signs (e.g., swollen joint, enthesitis, or psoriatic plaque). It aims to assess the impact of biological therapies on liver disorders, joints, and skin in PsA patients.

PhaseNA
TypeInterventional
AgeAny
WhereSan Diego, California, United States
SponsorUniversity of California, San Diego
▾Tap for details
Apply

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

NCT02103361 · Psoriasis, Pregnancy, Psoriatic Arthritis
Recruiting

The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for one year after birth. With respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be relevant to a medication exposure during pregnancy, and these include both easily recognizable defects which are visible at birth, as well as more subtle or delayed defects that may not be readily identifiable without special expertise and observation beyond the newborn period.

Phase—
TypeObservational
AgeAny
WhereLa Jolla, California, United States
SponsorUniversity of California, San Diego
▾Tap for details
Apply

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

NCT02418442 · Rheumatic Joint Disease
Recruiting

Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.

Phase—
TypeObservational
Age21 Years
WhereBirmingham, Alabama, United States + 81 more
SponsorDuke University
▾Tap for details
Apply